Electrophysiologic mechanisms of perpetuation of atrial fibrillation

American Journal of Cardiology

Volumn 77, Issue 3, 1996, Pages 10A-23A

  Allessie, Maurits A ^a   Konings, Karen ^a   Kirchhof, Charles J H J ^a   Wijffels, Maurits ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; ANTIARRHYTHMIC AGENT; LIDOCAINE; OUABAIN; PROPAFENONE; QUINIDINE; SOTALOL;

ADOLESCENT; ADULT; ANIMAL MODEL; ARRHYTHMOGENESIS; CLINICAL ARTICLE; CONFERENCE PAPER; DRUG EFFECT; ELECTROCARDIOGRAM; HEART ATRIUM FIBRILLATION; HEART ELECTROPHYSIOLOGY; HEART SUPRAVENTRICULAR ARRHYTHMIA; HUMAN; NONHUMAN; PRIORITY JOURNAL; REFRACTORY PERIOD; SINUS RHYTHM;

EID: 0030053049     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(97)89114-X     Document Type: Conference Paper

References (56)

1. Godtfredsen J. Atrial Fibrillation. Etiology, course and prognosis. A follow-up study of 1,212 cases. Dr Med thesis, Univ. Copenhagen, Munksgaard, 1975.
2. Petersen P, Godtfredsen J. Atrial Fibrillation - a review of course and prognosis. Acta Med Scand 1984;216:5-9.
3. Alpert JS, Petersen P, Godtfredsen J. Atrial fibrillation: natural history, complications and management. Ann Rev Med 1988;39:41-52.
4. Evans W, Swann P. Lone auricular fibrillation. Br Heart J 1954;16:189-194.
5. Kannel WB, Abbott RD, Savage DD, McNamara PM. Epidemiologic features of chronic atrial fibrillation. The Framingham Study. N Engl J Med 1982;307:1018-1022.
6. Brand FN, Abbott RD, Kannel WB, Wolf PA. Characteristics and prognosis of lone atrial fibrillation. 30-Year follow-up in the Framingham study. JAMA 1985;254:3449-3453.
7. Kopecky SL, Gersh BJ, McGoon MD, Whisnant JP, Holmes DR, Ilstrup DM, Frye RL. The natural history of lone atrial fibrillation. A population-based study over three decades. N Eng J Med 1987;317:669-674.
8. In: Kingma JH, Van Hemel NM, Lie KI, eds. Atrial fibrillation, a treatable disease? Amsterdam: Kluwer Academic Publishers 1992:
9. Moore EN, Spear JF. Natural occurrence and experimental initiation of atrial fibrillation in different animal species. In: Kulbertus HE, Olsson SB, Schlepper M, eds. Atrial Fibrillation. Molndal, Sweden: Lindgren and Soner, 1982:33-41.
10. Wijffels MCEF, Kirchhof CJHJ, Boersma LVA, Allessie MA. Atrial fibrillation begets atrial fibrillation. In: Olsson SB, Allessie MA, Campbell RWF, eds. Atrial fibrillation - Mechanisms and Therapeutic Strategies. Armonk, New York: Futura Publishing, 1994;195-201.
11. Allessie MA, Lammers WJEP, Smeets JRLM, Bonke FIM, Hollen J. Total mapping of atrial excitation during acetylcholine-induced atrial flutter and fibrillation in the isolated canine heart. In: Kulbertus HE, Olsson SB, Schlepper M, eds. Atrial fibrillation. MoIndal, Sweden: Lindgren and Soner, 1982; 44-62.
12. Allessie MA, Lammers WJEP, Bonke FIM, Hollen J. Experimental evaluation of Moe's multiple wavelet hypothesis of atrial fibrillation. In: Zipes DP, Jalife J, eds. Cardiac Arrhythmias. New York: Grune & Stratton, 1985; 265-276.
13. Kirchhof CJHJ, Chorro F, Scheffer GJ, Brugada J, Konings K, Zetelaki Z, Allessie MA. Regional entrainment of atrial fibrillation studied by high-resolution mapping in open-chest dogs. Circulation 1993;88:736-749.
14. Wang Z, Pagé P, Nattel S. Mechanism of flecainide's antiarrhythmic action in experimental atrial fibrillation. Circ Res 1992;71:271-287.
15. Wang J, Bourne GW, Wang Z, Villemaire C, Talajic M, Nattel S. Comparative mechanism of antiarrhythmic drug action in experimental atrial fibrillation. Importance of use dependent effects on refractoriness. Circulation 1993;88: 1030-1044.
16. Cox JL, Canavan TE, Schuessler RB, Cain ME, Lindsay BD, Stone C, Smith PK, Corr PB, Boineau JB. The surgical treatment of atrial fibrillation II: Intraoperative electrophysiologic mapping and description of the electrophysiologic basis of atrial flutter and atrial fibrillation. J Thorac Cardiovasc Surg 1991;101:406-426.
17. Cox JL, Boineau JP, Schuessler RB, Kater KM, Lappas DG. Surgical interruption of atrial reentry as a cure for atrial fibrillation. In: Olsson SB, Allessie MA, Campbell RWF, eds. Atrial Fibrillation - Mechanisms and Therapeutic Strategies. Armonk, New York: Futura Publishing, 1994;373-404.
18. Konings KTS, Kirchhof CJHJ, Smeets JRLM, Wellens HJJ, Penn OC, Allessie MA. High density mapping of electrically induced atrial fibrillation in man. Circulation 1994;89:1665-1680.
19. Holm M, Blomstrom P, Brandt J, Johansson R, Luhrs C, Olsson SB. Determination of preferable directions of impulse propagation during atrial fibrillation by time averaging of multiple electrogram vectors. In: Olsson SB, Allessie MA, Campbell RWF, eds. Atrial Fibrillation - Mechanisms and Therapeutic Strategies. Armonk, New York: Futura Publishing, 1994;67-80.
20. Moe GK. On the multiple wavelet hypothesis of atrial fibrillation. Arch Int Pharmacodyn Ther 1962;140:183-188.
21. Hoffman BF, Rosen MR. Cellular mechanisms for cardiac arrhythmias. Circ Res 1981;49:1-15.
22. Schuessler RB, Kawamoto T, Hand DE, Mitsuno M, Bromberg BI, Cox JL, Boineau JP. Simultaneous epicardial and endocardial activation sequence mapping in the isolated canine atrium. Circulation 1993;88;250-263.
23. Hewlett AW, Wilson FN. Coarse auricular fibrillation in man. Arch Intern Med 1915;15:786-793.
24. Nelson RM, Jenson CB, Davis RW. Differential atrial arrhythmias in cardiac surgical patients. J Thorac Cardiovasc Surg 1969;58:581-587.
25. Wells JL, Karp RB, Kouchoukos NT, MacLean WAH, James TN, Waldo AL. Characterization of atrial fibrillation in man: studies following open heart surgery. PACE 1978;1:426-438.
26. Waldo AL. Atrial fibrillation following open heart surgery. In: Olsson SB, Allessie MA, Campbell RWF, eds. Atrial Fibrillation - Mechanisms and Therapeutic Strategies. Armonk, New York: Futura Publishing, 1994;211-223.
27. Allessie MA, Bonke FIM, Schopman FJG. Circus movement in rabbit atrial muscle as a mechanism of tachycardia. II. The role of nonuniform recovery of excitability in the occurrence of unidirectional block as studied with multiple microelectrodes. Circ Res 1976;39:168-177.
28. Boineau JP, Schuessler RB, Mooney CR, Miller CB, Wylds AC, Hudson RD, Borremans JM, Brockus CW. Natural and evoked atrial flutter due to circus movement in dogs. Am J Cardiol 1980;45:1167-1181.
29. Spach MS, Miller WT, Geselowitz DB, Barr RC, Kootsey JM, Johnson EA. The discontinuous nature of propagation in normal canine cardiac muscle. Circ Res 1981;48:39-54.
30. Spach MS, Kootsey JM, Sloan JD. Active modulation of electrical coupling between cardiac cells of the dog: A mechanism for transient and steady state variations in conduction velocity. Circ Res 1982;51:347-362.
31. Spach MS, Dolber PC. Relating extracellular potentials and their derivatives to anisotropic propagation at a microscopic level in human cardiac muscle. Circ Res 1986;58:356-371.
32. Spach MS, Josephson ME. Initiating reentry: The role of nonuniform anisotropy in small circuits. J Cardiovasc Electrophysiol 1994;5:182-209.
33. Lewis T. The Mechanism and Graphic Registration of the Heart Beat. London: Shaw & Sons, 1925:
34. Wiener N, Rosenblueth A. The mathematical formulation of the problem of conduction of impulses in a network of connected excitable elements, specifically in cardiac muscle. Arch Inst Cardiol Mex 1946;16:205-265.
35. Smeets JLRM, Allessie MA, Lammers WJEP, Bonke FIM, Hollen SJ. The wavelength of the cardiac impulse and reentrant arrhythmias in isolated rabbit atrium. Circ Res 1986;58:96-108.
36. Rensma PL, Allessie MA, Lammers WJEP, Bonke FIM, Schalij MJ. The length of the excitation wave as an index for the susceptibility to reentrant atrial arrhythmias. Circ Res 1988;62:395-410.
37. Spach MS, Dolber PC, Heidlage JF. Interaction of inhomogeneities of repolarization with anisotropic propagation in dog atria. A mechanism for both preventing and initiating reentry. Circ Res 1989;65:1612-1631.
38. Winfree A. Understanding the onset of fibrillation in the heart muscle: Two-dimensional vortices in healthy myocardium. In: Science at the John von Neumann Supercomputer Center. Consortium for Scientific Computing. Princeton, 1988;125-130.
39. Allessie MA, Kirchhof CJHJ, Scheffer GJ, Chorro FJ, Brugada J. Regional control of atrial fibrillation by rapid pacing in conscious dogs. Circulation 1991;84:1689-1697.
40. Allessie MA, Bonke FIM, Schopman FJG. Circus movement in rabbit atrial muscle as a mechanism of tachycardia. III. The "leading circle" concept: a new model of circus movement in cardiac tissue without the involvement of an anatomic obstacle. Circ Res 1977;41:9-18.
41. Davidenko JM, Delmar M, Beaumont J, Michaels DC, Lorente P, Jalife J. Electrotonic inhibition and active facilitation of excitability in ventricular muscle. J Cardiovasc Electrophysiol 1994;5:945-960.
42. Joyner RW, Overholt ED, Ramza B, Veenstra RD. Propagation through electrically coupled cells: Two inhomogeneously coupled cardiac tissue layers. Am J Physiol 1984;247:596-609.
43. Allessie MA, Schalij MJ, Kirchhof CJHJ, Boersma L, Huybers M, Hollen SJ. Experimental electrophysiology and arrhythmogenecity. Anisotropy and ventricular tachycardia. Eur Heart J 1989;10(suppl):2-8.
44. Davidenko JM, Pertsov AV, Salomonsz R, Baxter W, Jalife J. Stationary and drifting spiral waves of excitation in isolated cardiac muscle. Nature 1992;355: 349-351.
45. Wijffels MCEF, Kirchhof CJHJ, Dorland R, Allessie MA. Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats. Circulation 1995;92:1954-1968.
46. Gold RL, Haffajee CI, Charos G, Sloan K, Baker S, Alpert JS. Amiodarone for refractory atrial fibrillation. Am J Cardiol 1986;57:124-127.
47. Crozier IG, Ikram H, Kenealy M, Levy L. Flecainide acetate for conversion of acute supraventricular tachycardia to sinus rhythm. Am J Cardiol 1987;59:607-609.
48. Crijns HJGM, Van Wijk LM, Van Gilst WH, Kingma HJ, van Gelder IC, Lie KI. Acute conversion of atrial fibrillation to sinus rhythm: clinical efficacy of flecainide acetate. Comparison of two regimens. European Heart J 1988;9: 634-638.
49. Bianconi L, Boccadamo R, Pappalardo A, Gentili C, Pistolese M. Effectiveness of intravenous propafenone for conversion of atrial fibrillation and flutter of recent onset. Am J Cardiol 1989;63:1275-1278.
50. Suttorp MJ, Kingma JH, Lie-A-Huen L, Mast EG. Intravenous Flecainide versus verapamil for acute conversion of paroxysmal atrial fibrillation or flutter to sinus rhythm. Am J Cardiol 1989;63:693-696.
51. Suttorp MJ, Kingma JH, Jessurun ER, Lie-A-Huen L, van Hemel NM, Lie KI. The value of class 1c antiarrhythmic drugs for acute conversion of paroxysmal atrial fibrillation or flutter to sinus rhythm. J Am Coll Cardiol 1990;16:1722-1727.
52. Van Gelder IC, Crijns HJGM, Van Gilst WH, Verwer R, Lie KI. Prediction of uneventful cardioversion and maintenance of sinus rhythm from direct-current electrical cardioversion of chronic atrial fibrillation and flutter. Am J Cardiol 1991;68:41-46.
53. Bjerkelund C, Orning O. An evaluation of DC shock treatment of atrial arrhythmias. Acta Med Scand 1968;184:481-491.
54. Attuel P, Childers R, Cauchemez B, Poveda J, Mugica J, Coumel P. Failure in the rate adaptation of the atrial refractory period: its relationship to vulnerability. Int J Cardiol 1982;2:179-197.
55. Attuel P, Childers RW, Haissaguerre M, Leclercq J, Mugica J, Coumel R. Failure in the rate adaptation of the atrial refractory period: new parameter to assess atrial vulnerability. PACE 1984;7:1382.
56. Le Heuzey JY, Boutjdir M, Gagey S, Lavergne T, Guize L. Cellular aspects of atrial vulnerability. In: Attuel P, Coumel P, Janse MJ, eds. The Atrium in Health and Disease. Mount Kisco, New York: Futura Publishing, 1989;81-94.